Related Experiment Video
Updated: Jun 3, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Diabetes and urothelial cancer risk: the Multiethnic Cohort study
Christy G Woolcott1, Gertraud Maskarinec, Christopher A Haiman
1Perinatal Epidemiology Research Unit, Department of Obstetrics & Gynecology, Dalhousie University, Halifax, NS, Canada.
Background:
It is important to understand the adverse health sequelae that may result from the rising incidence of diabetes. Diabetics may have an increased risk for urothelial cancer but the evidence from prospective studies and ethnically diverse populations is sparse.
Method:
We examined this association in the Multiethnic Cohort (MEC) that was conducted in Hawaii and Los Angeles with nearly 186,000 participants in five ethnic groups. Over a median 10.7 years of follow-up, 918 incident cases of urothelial cancer (89% bladder and 11% other urinary tract sites) were identified through tumor registry linkages.
Results:
A self-reported diagnosis of diabetes was associated with an increased risk of urothelial cancer (relative risk=1.25; 95% confidence interval: 1.04-1.50). The association was not explained by body mass index, physical activity, or smoking. There was some suggestion that the risk was higher in women, Whites and African Americans, and past smokers. The risk associated with diabetes for in situ and localized cancer was similar to that for regional and distant cancer.
Conclusion:
This study demonstrates that the increased urothelial cancer risk with diabetes in this multiethnic population is very similar to that observed in mostly White or Asian populations. Whether or not the elevated risk is moderated by the degree of control of the hyperglycemia associated with diabetes will need to be determined in future studies.
Related Concept Videos
Diabetic Nephropathy
Diabetes Mellitus: Type 2 and Gestational
Psychoneuroimmunology: Diabetes and Cancer
Type II Diabetes II: Pathophysiology
Type I Diabetes II: Pathophysiology
Diabetic Retinopathy